# Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs

> **NCT02639520** · PHASE3 · COMPLETED · sponsor: **Bionorica SE** · enrollment: 659 (actual)

## Conditions studied

- Urinary Tract Infection

## Interventions

- **DRUG:** Canephron® N
- **DRUG:** Fosfomycin trometamol
- **DRUG:** Canephron® N-placebo
- **DRUG:** Fosfomycin trometamol-placebo

## Key facts

- **NCT ID:** NCT02639520
- **Lead sponsor:** Bionorica SE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-06
- **Final completion:** 2017-06-29
- **Target enrollment:** 659 (ACTUAL)
- **Last updated:** 2017-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02639520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02639520, "Efficacy of CLR Compared to Fosfomycin Trometamol in Acute Lower uUTIs". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02639520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*